Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Feds to spend $1.5B over three years to improve access to drugs for rare diseases | 24CA News

Health
Published 22.03.2023
Feds to spend .5B over three years to improve access to drugs for rare diseases  | 24CA News

The federal authorities says it’ll spend as much as $1.5 billion over the following three years to enhance entry to medicine used to deal with uncommon ailments.

Health Minister Jean-Yves Duclos says as much as $1.4 billion of that cash might be used to assist provinces and territories broaden protection of latest and present medicine that deal with uncommon ailments.

The federal authorities says it desires to create an inventory of latest and rising medicine for uncommon ailments that may be coated in an identical approach by all provincial and territorial medical insurance plans.

Another $52 million might be used to collect proof on the protection and effectiveness of those medicine in addition to for analysis on diagnostic instruments and making a scientific trials community.

Story continues beneath commercial

And $33 million will go to Indigenous Services Canada to assist eligible First Nations and Inuit sufferers with uncommon ailments

The authorities says one in 12 Canadians has a uncommon illness, and that revolutionary remedies for these ailments can price between $100,000 and $2 million per yr.